Antioxidant activities of dracocephalum tanguticum maxim extract and its up-regulation on the expression of neurotrophic factors in a rat model of permanent focal cerebral ischemia

American Journal of Chinese Medicine

Volumn 39, Issue 1, 2011, Pages 65-81

  Xu, Jin Xiu ^a   Yang, Mu ^a   Deng, Ke Jun ^a   Zhou, Hong ^a  

^a UNIVERSITY OF ELECTRONIC SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Antioxidant; Dracocephalum tanguticum Maxim (D. tanguticum); Flavonoids; Neurobehavioral Evaluation; Neurotrophic Factor Expression; Permanent Focal Cerebral Ischemia

Indexed keywords

ANTIOXIDANT; BRAIN DERIVED NEUROTROPHIC FACTOR; BUTANOL; CATALASE; CHLOROFORM; DRACOCEPHALUM TANGUTICUM EXTRACT; FLAVONOID; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MESSENGER RNA; NEUROTROPHIN 3; PLANT EXTRACT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; CONVALESCENCE; DRACOCEPHALUM TANGUTICUM; DRUG MECHANISM; ENZYME ACTIVITY; FRONTAL CORTEX; GENE EXPRESSION; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; MEDICINAL PLANT; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; SOLVENT EXTRACTION; UPREGULATION;

ANIMALS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; BRAIN; BRAIN ISCHEMIA; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; FLAVONOIDS; INFARCTION, MIDDLE CEREBRAL ARTERY; LAMIACEAE; MALE; MALONDIALDEHYDE; NERVE GROWTH FACTORS; NEUROTROPHIN 3; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; UP-REGULATION;

EID: 78751485093     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X11008658     Document Type: Article

References (46)

1. Agar, E., M. Bosnak, R. Amanvermez, S. Demir, M. Ayyildiz and C. Celik. The effect of ethanol on lipid peroxidation and glutathione level in the brain stem of rat. Neuroreport 10: 1799-1801, 1999.
2. Akhlaghi, M. and B. Bandy. Mechanisms of flavonoid protection against myocardial ischemiareperfusion injury. J. Mol. Cell. Cardiol. 46: 309-317, 2009.
3. Allen, G.V., D. Gerami and M.J. Esser. Conditioning effects of repetitive mild neurotrauma on motor function in an animal model of focal brain injury. Neuroscience 99: 93-105, 2000.
4. An, L., Y.Z. Zhang, N.J. Yu, X.M. Liu, N. Zhao, L. Yuan, H.X. Chen and Y.F. Li. The total flavonoids extracted from Xiaobuxin-Tang up-regulate the decreased hippocampal neurogenesis and neurotrophic molecules expression in chronically stressed rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 32: 1484-1490, 2008.
5. Appelberg, K.S., D.A. Hovda and M.L. Prins. The effects of a ketogenic diet on behavioral outcome after controlled cortical impact injury in the juvenile and adult rat. J. Neurotrauma 26: 497-506, 2009.
6. Armstrong, D. and R. Browne. The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. Adv. Exp. Med. Biol. 366: 43-58, 1994.
7. Barber, P.A., L. Hoyte, D. Kirk, T. Foniok, A. Buchan and U. Tuor. Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T. Neurosci. Lett. 388: 54-59, 2005.
8. Bederson, J.B., L.H. Pitts, M. Tsuji, M.C. Nishimura, R.L. Davis and H. Bartkowski. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17: 472-476, 1986.
9. Chance, B. and A.C. Maehly. Assay catalases and peroxidases. Meth. Enzymol. 2: 764-768, 1995.
10. Durukan, A., D. Strbian and T. Tatlisumak. Rodent models of ischemic stroke: a useful tool for stroke drug development. Curr. Pharm. Des. 14: 359-370, 2008.
11. Fernagut, P.O., E. Diguet, B. Labattu and F. Tison. A simple method to measure stride length as an index of nigrostriatal dysfunction in mice. J. Neurosci. Methods 113: 123-130, 2002.
12. Ga, M.Q.P., X.J.Z. Yi, D. Zhan and Y.B.Z. Ci (eds.). Chinese Materia Medica-Tibetan Medicine. Shanghai Science and Technology Press, Shanghai, China, 2002, pp. 278-279.
13. Galvin, K.A. and D.E. Oorschot. Continuous low-dose treatment with brain-derived neurotrophic factor or neurotrophin-3 protects striatal medium spiny neurons from mild neonatal hypoxia/ ischemia: a stereological study. Neuroscience 118: 1023-1032, 2003.
14. Ginsberg, M.D. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 55: 363-389, 2008.
15. Hai, P., S. Zhou, H. Shang and G. Zhao. Antianoxic effects of Dracocephalum tanguticum on brain of mice. Zhong Yao Cai 20: 198-200, 1997.
16. Li, Y., Z. Xu, G.D. Ford, D.R. Croslan, T. Cairobe, Z. Li and B.D. Ford. Neuroprotection by neuregulin-1 in a rat model of permanent focal cerebral ischemia. Brain Res. 1184: 277-283, 2007.
17. Li, Y.F., C.J. Guo, J.J. Yang, J.Y. Wei, J. Xu and S. Cheng. Evaluation of antioxidant properties of pomegranate peel extract in comparison with pomegranate pulp extract. Food Chem. 96: 254-260, 2006.
18. Lindvall, O., P. Ernfors, J. Bengzon, Z. Kokaia, M.L. Smith, B.K. Siesjo and H. Persson. Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc. Natl. Acad. Sci. USA. 89: 648-652, 1992.
19. Lin, L.L., A.J. Liu, J.G. Liu, X.H. Yu, L.P. Qin and D.F. Su, Protective effects of scutellarin and breviscapine on brain and heart ischemia in rats. J. Cardiovasc. Pharmacol. 50: 327-332, 2007.
20. Lin, C.H., F.C. Cheng, Y.Z. Lu, L.F. Chu, C.H. Wang and C.M. Hsueh. Protection of ischemic brain cells is dependent on astrocyte-derived growth factors and their receptors. Exp. Neurol. 201: 225-233, 2006.
21. Lipton, P. Ischemic cell death in brain neurons. Physiol. Rev. 79: 1431-1568, 1999.
22. Liu, C., J. Wu, J. Gu, Z. Xiong, F. Wang, J. Wang, W. Wang and J. Chen. Baicalein improves cognitive deficits induced by chronic cerebral hypoperfusion in rats. Pharmacol. Biochem. Behav. 86: 423-430, 2007a.
23. Liu, L., Z. Wang, X. Wang, L. Song, H. Chen, C. Bemeur, L. Ste-Marie and J. Montgomery. Comparison of two rat models of cerebral ischemia under hyperglycemic conditions. Microsurgery 27: 258-262, 2007b.
24. Liu, G., Z. Xu, J. Chen, G. Lang, Q. Tian, Y. Shen, B. Chen and S. Yao. On-line strategies for the identification of unknown flavone glycosides in Dracocephalum tanguticum Maxim. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877: 2545-2550, 2009.
25. Longa, E.Z., P.R. Weinstein, S. Carlson and R. Cummins. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91, 1989.
26. Lykissas, M.G., A.K. Batistatou, K.A. Charalabopoulos and A.E. Beris. The role of neurotrophins in axonal growth, guidance, and regeneration. Curr. Neurovasc. Res. 4: 143-151, 2007.
27. McCord, J.M. and I. Fridovich. Superoxide dismutase: the first twenty years (1968-1988). Free Radic. Biol. Med. 5: 363-369, 1988.
28. Nagel, S., M. Papadakis, R. Chen, L.C. Hoyte, K.J. Brooks, D. Gallichan, N.R. Sibson, C. Pugh and A.M. Buchan. Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 2010, doi:10.1038/jcbfm. 2010.60.
29. Petullo, D., K. Masonic, C. Lincoln, L. Wibberley, M. Teliska and D.L. Yao. Model development and behavioral assessment of focal cerebral ischemia in rats. Life Sci. 64: 1099-1108, 1999.
30. Shang, Y.Z., H. Miao, J.J. Cheng and J.M. Qi. Effects of amelioration of total flavonoids from stems and leaves of Scutellaria baicalensis Georgi on cognitive deficits, neuronal damage and free radicals disorder induced by cerebral ischemia in rats. Biol. Pharm. Bull. 29: 805-810, 2006.
31. Slemmer, J.E., J.J. Shacka, M.I. Sweeney and J.T. Weber. Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Curr. Med. Chem. 15: 404-414, 2008.
32. STAIR. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 30: 2752-2758, 1999.
33. Sun, H.S., T.A. Doucette, Y. Liu, Y. Fang, L. Teves, M. Aarts, C.L. Ryan, P.B. Bernard, A. Lau, J.P. Forder, M.W. Salter, Y.T. Wang, R.A. Tasker and M. Tymianski. Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat. Stroke 39: 2544-2553, 2008.
34. Sydserff, S.G., A.R. Borelli, A.R. Green and A.J. Cross. Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window. Br. J. Pharmacol. 135: 103-112, 2002.
35. Takeda, A., H. Onodera, A. Sugimoto, K. Kogure, M. Obinata and S. Shibahara. Coordinated expression of messenger RNAs for nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 in the rat hippocampus following transient forebrain ischemia. Neuroscience 55: 23-31, 1993.
36. Tessarollo, L., V. Coppola and B. Fritzsch. NT-3 replacement with brain-derived neurotrophic factor redirects vestibular nerve fibers to the cochlea. J. Neurosci. 24: 2575-2584, 2004.
37. Warner, D.S., H. Sheng and I. Batinic-Haberle. Oxidants, antioxidants and the ischemic brain. J. Exp. Biol. 207: 3221-3231, 2004.
38. Weng, Y.C. and J. Kriz. Differential neuroprotective effects of a minocycline-based drug cocktail in transient and permanent focal cerebral ischemia. Exp. Neurol. 204: 433-442, 2007.
39. Williams, C.M., M.A. El Mohsen, D. Vauzour, C. Rendeiro, L.T. Butler, J.A. Ellis, M. Whiteman and J.P. Spencer. Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels. Free Radic. Biol. Med. 45: 295-305, 2008.
40. Xu, J.X., M. Yang and H. Zhou. Establishment of a rat permanent middle cerebral artery occlusion (pMCAO) model. Sichuan J. Zool. 29: 461-465, 2010.
41. Yang, W.J., D.P. Li, J.K. Li, M.H. Li, Y.L. Chen and P.Z. Zhang. Synergistic antioxidant activities of eight traditional chinese herb pairs. Biol. Pharm. Bull. 32: 1021-1026, 2009.
42. Yu, X.Q., C.C. Xue, Z.W. Zhou, C.G. Li, Y.M. Du, J. Liang and S.F. Zhou. In vitro and in vivo neuroprotective effect and mechanisms of glabridin, a major active isoflavan from Glycyrrhiza glabra (licorice). Life Sci. 82: 68-78, 2008.
43. Yu, T., Q.E. Chen, Z.W. Chen, Z. Xiong and M. Ye. Protective effects of total flavones of rhododendra against global cerebral ischemia reperfusion injury. Am. J. Chin. Med. 37: 877-887, 2009.
44. Zhang, X.F., B.L. Hu and S.X. Wang. The chemical constituents from Dracocephalum Tanguticum Maxim. Acta Bot. Sin. 36: 645-648, 1994.
45. Zhang, Y., X. Wang, X. Wang, Z. Xu, Z. Liu, Q. Ni, X. Chu, M. Qiu, A. Zhao and W. Jia. Protective effect of flavonoids from Scutellaria baicalensis Georgi on cerebral ischemia injury. J. Ethnopharmacol. 108: 355-360, 2006.
46. Zhao, G.P., S. Dai and R.S. Chen (eds.). Dictionary of Chinese Medicines. Shanghai Science and Technology Press, Shanghai, China, 2006, pp. 2687-2688.